Business Context and Reporting Period
This Form 6-K filing by Eni S.p.A. covers the period ending February 29, 2016, and includes press releases from late February 2016 alongside the company's preliminary fourth-quarter and full-year 2015 financial results. The reporting period is characterized by a strategic transformation to focus on core oil and gas businesses, the completion of the deconsolidation of the Saipem engineering and construction subsidiary, and significant operational milestones in Egypt and Mozambique.
Key Financial Metrics
| Metric | Q4 2015 | FY 2015 | FY 2014 |
|---|---|---|---|
| Net Sales (Continuing Ops) | €13.89 billion | €67.74 billion | €93.19 billion |
| Adjusted Operating Profit (Continuing Ops) | €0.98 billion | €3.79 billion | €10.45 billion |
| Reported Net Loss (Group) | €8.46 billion | €8.82 billion | €1.29 billion profit |
| Operating Cash Flow (Continuing Ops) | €4.01 billion | €12.19 billion | €14.39 billion |
| Capital Expenditure (Continuing Ops) | €2.68 billion | €10.78 billion | €11.26 billion |
| Net Borrowings | €16.86 billion | €16.86 billion | €13.69 billion |
| Leverage Ratio | 0.31 | 0.31 | 0.22 |
| Hydrocarbon Production | 1.88 million boe/d | 1.76 million boe/d | 1.60 million boe/d |
Note: Reported net loss includes significant asset impairments and discontinued operations. Adjusted metrics exclude special items and inventory holding losses.
Material Changes vs. Prior Period
- Revenue Decline: Full-year net sales dropped 27.3% year-over-year, driven by a 47% decline in Brent crude prices (averaging $52.46/bbl in 2015 vs. $98.99/bbl in 2014).
- Profitability Impact: Standalone adjusted operating profit from continuing operations fell 64% to €4.1 billion for the full year. Reported earnings turned negative due to €4.8 billion in asset impairments and €1.97 billion in impairment charges related to discontinued operations (Saipem and Versalis).
- Production Growth: Despite lower prices, hydrocarbon production increased 10% year-over-year to 1.76 million boe/d, reaching a 5-year high in Q4.
- Cost Efficiency: Capital expenditure was reduced by 17% (vs. initial guidance of 14%), and operating expenses per boe decreased by 13%.
- Discontinued Operations: Saipem and Versalis were classified as discontinued operations effective for the full year, impacting the presentation of financial results.
Guidance, Outlook, and Management Commentary
- Strategic Transformation: Management confirmed the completion of the Saipem transaction, generating €4.8 billion in net proceeds, which reduced pro-forma leverage to 0.22. The company is exiting the Engineering & Construction and Chemical sectors to focus on core E&P, Gas & Power, and Refining & Marketing.
- 2016 Outlook:
- Production: Expected to be flat year-over-year, offsetting mature field declines with new start-ups in Norway, Egypt, Angola, and the US.
- Gas Sales: Expected to be slightly down due to weak demand and contract renegotiations.
- Capex: Planned reduction of 20% year-over-year; management forecasts capex will be 100% funded by operating cash flow under a $50/bbl oil price scenario.
- Refining: Margins expected to remain profitable but lower than 2015 levels.
- Dividend: The Board confirmed a total dividend of €0.80 per share for FY2015 (€0.40 interim paid in Sept 2015; €0.40 final proposed).
- Major Projects:
- Zohr (Egypt): Development plan approved; production start expected end of 2017, ramping to 75 million scm/day by 2019.
- Coral (Mozambique): First phase development plan approved for 5 Tcf of gas; includes a Floating LNG facility (3.4 MTPA).
- Risks: Continued low oil prices, structural market imbalances, geopolitical risks in operating regions, and the timing of new field start-ups.
Investor Verification Checklist
- Impairment Details: Verify the specific assets and cash-generating units (CGUs) impacted by the €4.8 billion impairment charge, particularly in high-cost areas (USA, UK, Norway, Angola).
- Saipem Transaction: Confirm the final terms of the 12.5% stake sale to FSI and the joint control agreement, and monitor the valuation of the remaining interest.
- Discontinued Operations: Review the standalone financial performance of Saipem and Versalis to understand the full scope of the divestment impact.
- Reserve Replacement: Validate the 148% organic reserve replacement ratio, specifically the contribution of the Zohr discovery and other new finds.
- Working Capital: Assess the sustainability of the €2.2 billion positive non-recurring working capital impact in 2015.
- Gas Contract Renegotiations: Monitor the progress of renegotiating long-term gas supply contracts to align with current market conditions.